Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153

British Journal of Cancer

Volumn 73, Issue 1, 1996, Pages 18-23

  Gately, D P ^a   Sharma, A ^b   Christen, R D ^b   Howell, S B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Cellular injury response; Cisplatin; GADD153; Taxol; Tyrphostin B46

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC METAL COMPLEX; CISPLATIN; LUCIFERASE; MESSENGER RNA; PACLITAXEL; TRANSFERASE INHIBITOR; TYRPHOSTIN;

ARTICLE; CARCINOMA CELL; CELL CYCLE; CELL DAMAGE; CELL DEATH; CELL SURVIVAL; DRUG CYTOTOXICITY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION;

EID: 0030060745     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.4     Document Type: Article

References (35)

1. ÅMAN P, RON D, MANDAHL N, FIORETOS T, HEIM S, ARHEDEN K, WILLEN H, RYDHOLM A AND MITELMAN F. (1992). Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chrom. Cancer, 5, 278-285.
2. BARLETT JD, LUETHY JD, CARLSON SG, SOLLOTT SJ AND HOLBROOK NJ. (1992). Calcium ionophore A23187 induces expression of the growth arrest and DNA damage inducible CCAAT/enhancer-binding protein (C/EBP)-related gene gadd153. J. Biol. Chem., 267, 20465-20470.
3. 1/S arrest. Genes Dev., 8, 453-464.
4. BRASIER AR, TATE JE AND HABENER JF. (1989). Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. BioTechniques, 7, 1116-1122.
5. CHEN Q, YU K, HOLBROOK NJ AND STEVENS JL. (1992). Activation of the growth arrest and DNA damage-inducible gene gadd 153 by nephrotoxic cysteine conjugates and dithiothreitol. J. Biol. Chem., 267, 8207-8212.
6. CHOU T-C AND TALALAY P. (1986). Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul., 22, 27-55.
7. CROZAT A, AMAN P AND RON D. (1993). Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature, 363, 640-644.
8. DAVIS LG, DIBNER MD AND BATTEY JF. (1986). Basic Methods in Molecular Biology. Elsevier Science: New York.
9. DEVARY Y, GOTTLIEB RA, SMEAL T AND KARIN M. (1992). The mammalian ultraviolet response is triggered by activation of Src tyrosine kinase. Cell, 71, 1081-1091.
10. DEVARY Y, ROSETTE C, DIDONATO JA AND KARIN M. (1993). NF-kB activation by ultraviolet light not dependent on a nuclear signal. Science, 261, 1442-1445.
11. DISAIA PJ, SINKOVICS JG, RUTLEDGE FN AND SMITH JP. (1972). Cell-mediated immunity to human malignant cells. Am. J. Obstet. Gynecol., 114, 979-989.
12. FORNACE AJ, ALAMO I AND HOLLANDER MC. (1988). DNA damage-inducible transcripts in mammalian cells. Proc. Natl Acad. Sci. USA, 85, 8800-8804.
13. FORNACE AJ, NEBERT DW, HOLLANDER C, LUETHY JD, PAPATHANASIOU M, FARGNOLI J AND HOLBROOK N. (1989). Mammalian genes coordinately regulated by growth arrest signal and DNA damaging agents. Mol. Cell. Biol., 9, 4196-4203.
14. FORNACE AJ, JACKMAN J, HOLLANDER MC, HOFFMAN-LIEBERMANN B AND LIEBERMANN DA. (1992). Genotoxic-stressresponse genes and growth-arrest genes. Ann. NY Acad. Sci., 139-153.
15. GATELY DP, JONES JA, CHRISTEN RC, BARTON RB, LOS G AND HOWELL SB. (1994). Induction of the growth arrest and DNA damage inducible gene GADD153 by cisplatin in vitro and in vivo. Br. J. Cancer, 70, 1102-1106.
16. GAZIT A, YAISH P, GILON C AND LEVITZKI A. (1989). Tyrphostins I : Synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem., 32, 2344-2352.
17. GAZIT A, OHEROV N, POSNER I, YAISH P, GILON C AND LEVITZKI A. (1991). Tyrphostins 2: Heterocyclic and a-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases. J. Med. Chem., 34, 1896-1907.
18. HOLBROOK NJ AND FORNACE AJ. (1991). Response to adversity: molecular control of gene activation following genotoxic stress. New Biol., 3, 825-833.
19. HOLLANDER MC, ALAMO I, JACKMAN J, WANG MG, MCBRIDE W AND FORNACE AJ. (1993). Analysis of the mammalian gadd45 gene and its response to DNA damage. J. Biol. Chem., 32, 24385-24393.
20. JACKMAN J, ALAMO I AND FORNACE AJ. (1994). Genotoxic stress confers preferential and coordinate messenger RNA stability on the five gadd genes. Cancer Res., 54, 5656-5662.
21. KASTAN MB, ZHAN Q, EL-DIERY WS, CARRIER F, JACKS T, WALSH WV, PLANKETT BS, VOGELSTEIN B AND FORNACE AJ. (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71, 587-597.
22. KRAMER M, STEIN B, MAI S, KONIG H, LOFERER H, GRUNICKE HH, PONTA H, HERRLICH P AND RAHMSDORF HJ. (1990). Radiation-induced activation of transcription factors in mammalian cells. Radiat. Environ. Biophys., 29, 303-313.
23. LUETHY JD AND HOLBROOK NJ. (1992). Activation of the gadd 153 promoter by genotoxic agents: a rapid and specific response to DNA damage. Cancer Res., 52, 5-10.
24. LOUTHY JD AND HOLBROOK NJ. (1994). The pathway regulating GADD153 induction in response to DNA damage is independent of protein kinase C and tyrosine kinases. Cancer Res., 54, 1902s-1906s.
25. LUETHY JD, FARGNOLI J, PARK JS, FORNACE AJ AND HOLBROOK NJ. (1990). Isolation and characterization of the hamster gadd 153 gene. J. Biol. Chem., 265, 16521-16526.
26. PARK JS, LUETHY JD, WANG MG, FARGNOLI J, FORNACE AJ, MCBRIDE OW AND HOLBROOK NJ. (1992). Isolation, characterization and chromosomal localization of the human GADD153 gene. Gene, 116, 259-267.
27. PINTO AL AND LIPPARD SJ. (1985). Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA. Biochim. Biophys. Acta, 780, 167-180.
28. PRICE BD AND CALDERWOOD SK. (1992). Gadd45 and Gadd153 messenger RNA levels are increased during hypoxia and exposure of cells to agents which elevate the levels of glucose-related proteins. Cancer Res., 52, 3814-3817.
29. RON D AND HABENER JF. (1992). CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant negative inhibitor of gene transcription. Genes Dev., 6, 439-453.
30. ROSE JK, BUONOCORE L AND WHITT MA. (1991). A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechniques, 10, 520-525.
31. ROWINSKY EK, MCGUIRE WP AND DONEHOWER RC. (1993). The current status of taxol. In Principles and Practice of Gynecologic Oncology Updates, Hoskins WJ, Perez CA and Young RC. (eds). pp. 1-16. JB Lippincott: Philadelphia.
32. ROWLEY R, HUDSON J AND YOUNG PG. (1992). The weel protein kinase is required for radiation-induced mitotic delay. Nature, 356, 353-355.
33. WALKER GC. (1985). Inducible DNA repair systems. Annu. Rev. Biochem., 54, 425-457.
34. WEINERT TA AND HARTWELL LH. (1988). The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cervisiae. Science, 241, 317-322.
35. ZHAN Q, CARRIER F AND FORNACE AJ. (1993). Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol., 13, 4242-4250.